UTHR · earnings call history
United Therapeutics Q2 FY26 — Strong Pipeline Progress Despite Commercial Headwinds
Read the briefUnited Therapeutics Q1 FY26 — Pipeline Success Drives Significant Future Revenue Growth
Read the briefUnited Therapeutics Q4 FY25 — Transformative Product Launches and Strong Revenue Growth
Read the briefBrowse all US companies on the earnings-call register.